# Aligos Therapeutics, Inc. (ALGS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ALGS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 30.61M | $ -24.54M | $ -48.15M | $ 3.50M | $ 31.88M |
| 2025 | $ 2.24M | $ -24.77M | $ -84.92M | $ 5.25M | $ 53.55M |
| 2024 | $ 4.15M | $ -137.91M | $ -85.00M | $ 8.38M | $ -28.97M |
| 2023 | $ 16.79M | $ -94.80M | $ -85.44M | $ 11.14M | $ 92.08M |
| 2022 | $ 15.54M | $ -107.29M | $ -89.74M | $ 12.57M | $ 103.90M |
| 2021 | $ 5.18M | $ -152.54M | $ -138.54M | $ 14.46M | $ 184.73M |
| 2020 | $ 0 | $ -138.28M | $ -97.24M | $ 13.01M | $ 220.04M |
| 2019 | $ 0 | $ -67.46M | $ -63.96M | $ 14.33M | $ -64.89M |
| 2018 | $ 0 | $ -9.20M | $ -5.66M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.11 |
| Liabilities / Eq | 1.08 |
| Current Ratio | 2.19 |

## Other views

- [Metrics](https://sponda.capital/en/ALGS.md)
- [Charts](https://sponda.capital/en/ALGS/charts.md)
- [Compare](https://sponda.capital/en/ALGS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.